Stem cell treatment for widespread clogged heart arteries
Part of Heart & circulation clinical trials.
This Phase 1 study tests whether an “MCRcI” stem cell treatment is safe and may improve symptoms in people with widespread coronary artery disease (clogged heart arteries). It may help those with ongoing chest pain from angina despite proper heart medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have widespread clogged heart arteries causing angina (heart chest pain)
- You are between 20 and 80 years old
- You have been taking the right medications for your heart condition
- Your angina symptoms fall in class II to IV (ongoing chest pain with activity or even at rest)
- You can complete the heart procedures/tests the study requires (PCI exam or treatment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
This trial tests if combining a new heart procedure with a special type of therapy called mindfulness therapy can help prevent heart problems in people with coronary artery disease that could not be fully fixed with stents or surgery.
This study tests a new kind of coronary stent that slowly releases rapamycin to keep an artery open. You may be invited if you have a small number of specific, treatable blockages and can take the required blood-thinning medicines.
This trial is comparing two common heart procedures—bypass surgery (CABG) and stents (PCI)—to see which works better for women with blockages in multiple heart arteries. It aims to find the best treatment for women, who are often underrepresented in heart research.
This trial is testing whether a special heart CT scan (coronary CT angiography) can help doctors better understand and treat calcium buildup in your heart arteries. If you have a type of heart disease that might need a stent or other procedure, this study could help decide the best approach.
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.